About Shanghai MicroPort Endovascular MedTech(Group)Co.,Ltd. Company

The company was registered and established in the Shanghai International Medical Park in 2012 and listed on the Science and Technology Innovation Board in 2019. It is a national high-tech enterprise, the first batch of specialized and new “little giants” enterprises in the country, a national enterprise technology center, a national “green factory”, a small Shanghai science and technology giant enterprise, Shanghai Enterprise Technology Center, and an AAA credit enterprise, and won honors such as the Shanghai Quality Management Award, Shanghai Quality Benchmark, and Shanghai Brand. The company's business covers R&D, production, sales and service of aortic and peripheral vascular interventional medical devices. The company's products include thoracic aortic stent systems, abdominal aortic stent systems, intraoperative stent systems, balloon dilatation catheters, and pharmaceutical balloon dilatation catheters. Corporate honors: Won the “2018 Shanghai Science and Technology Little Giant Enterprise” qualification, selected as “2017 Shanghai Brand Cultivation Demonstration Enterprise” and “2018 Advanced Unit for Work Safety”, recognized as Shanghai Key Advantage Enterprise, Shanghai High-tech Enterprise, National First Batch of Specialized and New “Little Giant” Enterprises, Shanghai Enterprise Technology Center, Multinational Company R&D Center, AAA Credit Enterprise, and won the 3rd Pudong New Area Quality Gold Award, Shanghai Quality Management Award, Shanghai Quality Benchmark, Shanghai Brand, National Science and Technology Progress Award, and National Expert Honors such as a new “little giant” enterprise and “individual champion” in the manufacturing industry.